Skip to main content
SpringerLink
Log in

Polymorphisms of the farnesyl diphosphate synthase gene modulate bone changes in response to atorvastatin

  • Short Communication
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Although their primary therapeutic indications are different, aminobisphosphonates and statins target enzymes in the mevalonate pathway, which is critical for bone homeostasis. Previous studies have shown that some polymorphisms of the gene encoding farnesyl diphosphate synthase (FDPS), the main target of aminobisphosphonates, modulate the response to these drugs. In this study, we explored whether those single nucleotide polymorphisms (SNPs) also influence the changes in bone mineral density (BMD) following therapy with statins. Sixty-six patients with coronary heart disease were studied at baseline and after 1-year therapy with atorvastatin. BMD was measured by DXA. Three SNPs of the FDPS gene (rs2297480, rs11264359 and rs17367421) were analyzed by using Taqman assays. The results showed that there was no association between the SNPs and basal BMD. However, rs2297480 and rs11264359 alleles, which are in linkage disequilibrium, were associated with changes in hip BMD following atorvastatin therapy. Thus, patients with AA genotype at the rs2297480 locus had a 0.8 ± 0.8 % increase in BMD at the femoral neck, whereas in patients with AC/CC genotypes, BMD showed a 2.3 ± 0.8 % decrease (p = 0.02). Similar results were obtained regarding changes of BMD at the femoral trochanter and when alleles at the rs11264359 locus were analyzed. However, there was no association between BMD and rs17367421 alleles. In conclusion, these results suggest that polymorphisms of the FDPS gene may influence the bone response to various drugs targeting the mevalonate pathway, including not only aminobisphosphonates but also statins.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Hofbauer LC, Brueck CC, Shanahan CM, Schoppet M, Dobnig H (2007) Vascular calcification and osteoporosis—from clinical observation towards molecular understanding. Osteoporos Int 18:251–259

    Article  CAS  PubMed  Google Scholar 

  2. Bagger YZ, Rasmussen HB, Alexandersen P, Werge T, Christiansen C, Tanko LB (2007) Links between cardiovascular d and osteoporosis in postmenopausal women: serum lipids or atherosclerosis per se? Osteoporos Int 18:505–512

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685–1695

    Article  CAS  PubMed  Google Scholar 

  4. Perez-Castrillon JL, de Luis D, Duenas-Laita A (2008) Atherosclerosis and osteoporosis. Minerva Med 99:45–54

    CAS  PubMed  Google Scholar 

  5. Charlton-Menys V, Durrington PN (2008) Human cholesterol metabolism and therapeutic molecules. Exp Physiol 93:27–42

    Article  CAS  PubMed  Google Scholar 

  6. Rogers MJ, Crockett JC, Coxon FP, Monkkonen J (2011) Biochemical and molecular mechanisms of action of bisphosphonates. Bone 49:34–41

    Article  CAS  PubMed  Google Scholar 

  7. Rachner TD, Khosla S, Hofbauer LC (2011) Osteoporosis: now and the future. Lancet 377:1276–1287

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Horiuchi N, Maeda T (2006) Statins and bone metabolism. Oral Dis 12:85–101

    Article  CAS  PubMed  Google Scholar 

  9. Perez-Castrillón JL, Abad L, Vega G et al (2006) Effects of statins on bone markers, bone mineral density and fractures. Possible role in osteoporosis treatment. Curr Pharm Anal 2:161–168

    Article  Google Scholar 

  10. Yue J, Zhang X, Dong B, Yang M (2010) Statins and bone health in postmenopausal women: a systematic review of randomized controlled trials. Menopause 17:1071–1079

    Article  PubMed  Google Scholar 

  11. Olmos JM, Zarrabeitia MT, Hernandez JL, Sanudo C, Gonzalez-Macias J, Riancho JA (2012) Common allelic variants of the farnesyl diphosphate synthase gene influence the response of osteoporotic women to bisphosphonates. Pharmacogenomics J 12:227–232

    Article  CAS  PubMed  Google Scholar 

  12. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265

    Article  CAS  PubMed  Google Scholar 

  13. Conde L, Vaquerizas JM, Dopazo H et al (2006) PupaSuite: finding functional single nucleotide polymorphisms for large-scale genotyping purposes. Nucleic Acids Res 34:W621–W625

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Mundy G, Garrett R, Harris S et al (1999) Stimulation of bone formation in vitro and in rodents by statins. Science 286:1946–1949

    Article  CAS  PubMed  Google Scholar 

  15. Ruan F, Zheng Q, Wang J (2012) Mechanisms of bone anabolism regulated by statins. Biosci Rep 32:511–519

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Kim JY, Lee EY, Lee EB et al (2012) Atorvastatin inhibit osteoclastogenesis by decreasing the expression of RANKL in the synoviocytes of rheumatoid arthritis. ArthrRes Ther 14:R187

    Article  CAS  Google Scholar 

  17. O’Brien CA (2010) Control of RANKL gene expression. Bone 46:911–919

    Article  PubMed Central  PubMed  Google Scholar 

  18. Ericsson J, Jackson SM, Edwards PA (1996) Synergistic binding of sterol regulatory element-binding protein and NF-Y to the farnesyl diphosphate synthase promoter is critical for sterol-regulated expression of the gene. J Biol Chem 271:24359–24364

    Article  CAS  PubMed  Google Scholar 

  19. Ericsson J, Jackson SM, Lee BC, Edwards PA (1996) Sterol regulatory element binding protein binds to a cis element in the promoter of the farnesyl diphosphate synthase gene. Proc Natl Acad Sci USA 93:945–950

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Ishimoto K, Tachibana K, Hanano I et al (2010) Sterol-regulatory-element-binding protein 2 and nuclear factor Y control human farnesyl diphosphate synthase expression and affect cell proliferation in hepatoblastoma cells. Biochem J 429:347–357

    Article  CAS  PubMed  Google Scholar 

  21. Sato R (2010) Sterol metabolism and SREBP activation. Arch Biochem Biophys 501:177–181

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank the technical assistance of Veronica Mijares and Jana Arozamena.

Conflict of interest

Authors declare that they do not have conflicts of interest to declare.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Hospital Universitario Río Hortega, University of Valladolid, c/Dulzaina 2, 47010, Valladolid, Spain

    José L. Pérez-Castrillón, Laura Abad & Gemma Vega

  2. Unit of Legal Medicine, University of Cantabria, Santander, Spain

    María T. Zarrabeitia

  3. Centro Médico de Rehabilitación y Lenguaje, Valladolid, Spain

    Marta Ruiz-Mambrilla

  4. Unit of Investigation, Hospital Universitario Río Hortega, Valladolid, Spain

    Manuel Gonzalez-Sagredo

  5. Department of Clinical Pharmacology, Hospital Universitario Río Hortega, University of Valladolid, Valladolid, Spain

    Antonio Dueñas-Laita

  6. Department of Internal Medicine, Hospital U.M, Valdecilla, IFIMAV, RETICEF, University of Cantabria, Santander, Spain

    José A. Riancho

Authors
  1. José L. Pérez-Castrillón
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. María T. Zarrabeitia
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Laura Abad
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gemma Vega
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Marta Ruiz-Mambrilla
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Manuel Gonzalez-Sagredo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Antonio Dueñas-Laita
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. José A. Riancho
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to José L. Pérez-Castrillón.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pérez-Castrillón, J.L., Zarrabeitia, M.T., Abad, L. et al. Polymorphisms of the farnesyl diphosphate synthase gene modulate bone changes in response to atorvastatin. Rheumatol Int 34, 1073–1077 (2014). https://doi.org/10.1007/s00296-013-2914-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-013-2914-x

Keywords

Search

Navigation